Comparison of efficacy, safety, and cost-effectiveness of montelukast-levocetirizine and montelukast-fexofenadine in patients of allergic rhinitis: A randomized, double-blind clinical trial

OBJECTIVES: Allergic rhinitis (AR) is a global health problem. Almost 10%–25% of population worldwide is affected by AR. Oral/intranasal H1-antihistamine, decongestants, leukotriene receptor antagonists, and intranasal corticosteroids are the pillars in the management of AR. The combination therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahatme, Mohini Sachin, Dakhale, Ganesh Natthuji, Tadke, Kanchan, Hiware, Sachin Keshaorao, Dudhgaonkar, S. D., Wankhede, Sumit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155464/
https://www.ncbi.nlm.nih.gov/pubmed/28066101
http://dx.doi.org/10.4103/0253-7613.194854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155464/
https://www.ncbi.nlm.nih.gov/pubmed/28066101
http://dx.doi.org/10.4103/0253-7613.194854

Ejemplares similares